Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8645326 | Gene | 2018 | 9 Pages |
Abstract
The increased frequency of factor V Leiden G1691A and prothrombin G20210A mutation in VTE patients indicates a significant role of these mutations in the development of VTE in our population. We therefore suggest the routine screening of these two mutations as thrombophilic markers in Kashmiri patients with venous thromboembolism.
Keywords
SKIMSamplification-refractory mutation systemFVLmRNAMTHFRPTERFLPVTEARMSDNAEDTAEthylenediaminetetraacetic aciddeoxyribonucleic acidVenous thromboembolismPulmonary thromboembolismDVTDeep venous thrombosismessenger ribonucleic acidFactor V Leidenmethylene tetrahydrofolate reductasepolymerase chain reactionPCRprothrombinrestriction fragment length polymorphismKashmir
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Syed Shafia, Mahrukh H. Zargar, Nabeela Khan, Rehana Ahmad, Zafar Amin Shah, Ravouf Asimi,